SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-077187
Filing Date
2023-06-30
Accepted
2023-06-30 16:46:16
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tm2320218-1_s3.htm S-3 328923
2 EXHIBIT 5.1 tm2320218d2_ex5-1.htm EX-5.1 29514
3 EXHIBIT 23.1 tm2320218d2_ex23-1.htm EX-23.1 2957
4 EX-FILING FEES tm2320218d2_ex-filingfees.htm EX-FILING FEES 55594
5 GRAPHIC tm2320218d2_ex5-1img001.jpg GRAPHIC 3386
6 GRAPHIC lg_onconova-4c.jpg GRAPHIC 44062
  Complete submission text file 0001104659-23-077187.txt   483782
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-273081 | Film No.: 231062393
SIC: 2834 Pharmaceutical Preparations